Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion type Assertion NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_head.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion description "[Post-GVAX T-cell infiltration and aggregate formation resulted in the upregulation of immunosuppressive regulatory mechanisms, including the PD-1-PD-L1 pathway, suggesting that patients with vaccine-primed PDAC may be better candidates than vaccine-na�ve patients for immune checkpoint and other immunomodulatory therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion evidence source_evidence_literature NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion SIO_000772 24942756 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion wasDerivedFrom befree-2016 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.
- NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_assertion wasGeneratedBy ECO_0000203 NP1193564.RAV2NmI4XOLtDC_WvavClYBy1PRrrsOOYWEX0Rdiyr1q8130_provenance.